Nucynta Er Oral Tablet, Extended Release 100Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Nucynta ER: Oral tablet, extended release (100mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_19694.JPG
Nucynta ER 100mg Tablet
Janssen Pharmaceuticals, Inc
Pill Identification: OMJ 100 
Drug Image file DrugItem_19694.JPG
Nucynta ER 100mg Tablet
Janssen Pharmaceuticals, Inc
Pill Identification: OMJ 100 

What is this Medicine?

TAPENTADOL (ta PEN ta dol) is a pain reliever. It is used to treat moderate to severe pain that lasts for more than a few days. It is also used to treat nerve pain caused by diabetes.

CVS Pharmacy Patient Statistics for Nucynta ER: Oral tablet, extended release(100mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Nucynta ER 100mg Extended-Release Tablet

NDC: 504580861
  • Prescription Required
  • Federally Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Severe Pain, Neuropathic Pain, Moderate Pain

Storage Information
Protect from moisture
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Nucynta ER 100mg Extended-Release Tablet
Drug Image file DrugItem_19694.JPG
Janssen Pharmaceuticals, Inc
Pill Identification: OMJ 100 
Shape: oblong
Color: blue
Drug Image file DrugItem_16620.JPG
Janssen Pharmaceuticals, Inc
Pill Identification: OMJ 100 
Shape: oblong
Color: blue

Reported Side Effects for Nucynta ER 100mg Extended-Release Tablet

Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Decreased Breathing Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Fainting Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Confusion Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Dysarthria Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Elated Mood Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Hypoesthesia Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Hypoxia Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Decreased Thinking Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Increased Urination Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Irritability Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Paresthesias Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Addiction Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Psychomotor Impairment Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Restlessness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Weight Loss Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Decreased Memory Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Distressed Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Severe Allergy Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Slow Heart Beat Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Cough Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
<15.0%*
Severity: MILD
Onset: EARLY
Withdrawal Incidence:
0.9-12.0%*
Severity: MODERATE
Onset: EARLY
Shortness Of Breath Incidence:
0.9-1.1%*
Severity: MODERATE
Onset: EARLY
Infection Incidence:
1.0%*
Severity: MILD
Onset: DELAYED
Shaking Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Nervousness Incidence:
1.0-2.0%*
Severity: MILD
Onset: DELAYED
Depression Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Tiredness Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
Chills Incidence:
1.0%*
Severity: MILD
Onset: RAPID
Blurred Vision Incidence:
1.0%*
Severity: MODERATE
Onset: EARLY
Flushing Incidence:
1.0-2.0%*
Severity: MILD
Onset: RAPID
Sore Throat Incidence:
1.0%*
Severity: MILD
Onset: DELAYED
Impotence (erectile Dysfunction) Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Weakness Incidence:
2.0%*
Severity: MILD
Onset: DELAYED
Decreased Appetite Incidence:
2.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
2.0-3.0%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
2.0-4.0%*
Severity: MILD
Onset: EARLY
Balance Problems Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
3.0-5.0%*
Severity: MILD
Onset: RAPID
Excessive Sweating Incidence:
3.0-5.0%*
Severity: MILD
Onset: DELAYED
Tired Incidence:
3.0-9.0%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
4.0-7.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
8.0-18.0%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
8.0-17.0%*
Severity: MODERATE
Onset: DELAYED
Drowsiness Incidence:
12.0-15.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
17.0-24.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
21.0-30.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Nucynta ER 100mg Extended-Release Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Alcohol and Nucynta ER 100mg Extended-Release Tablet(Tapentadol)
Alcohol and Tapentadol(Tapentadol)
Do not drink Alcohol while you are taking Tapentadol. Do not take prescription or OTC medicines that have Alcohol in them if you are taking long-acting Tapentadol. You may get too much medicine. This can be a medical emergency. Get medical help right away if you get slurred speech, confusion, severe weakness, or difficulty breathing.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More